Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02870465
Other study ID # HHN-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 29, 2016
Est. completion date September 29, 2021

Study information

Verified date March 2022
Source Horizon Health Network
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main objective of this non-interventional, observational study is to analyze the rate and type of infection complications while performing closed reduction internal fixation (CRIF) of hand fractures in the operating room versus an ambulatory setting. The investigators will do so by prospectively collecting data on the type of fracture, handedness, co-morbidities, duration of treatment, number and type of K-wires, duration of fixation and complication rate. Patients presenting with hand fractures to the emergency room will be recruited. Patients will be recruited in multiple centres across Canada and managed according to the institutional standard. The complication type and rate will be recorded and analyzed to determine a difference of performing the procedure in the operating room or clinical setting.


Description:

The main objective of this study is to analyze the rate and type of infectious complications while performing closed reduction internal fixation (CRIF) of hand fractures in the operating room versus an ambulatory setting. The investigators will do so by prospectively collecting data into a hand fracture database, recording the type of fracture, handedness, co-morbidities, duration of treatment, number of K-wires, duration of fixation and complication rate. These will be recorded on a data collection form, which will be transcribed into a password protected excel spread sheet by Dr. Lalonde. The data will be de-identified and the patients will be assigned a number to place on the data collection sheet depending on order of presentation. The investigators will include all adult patients presenting with a metacarpal or phalangeal that is amenable to CRIF with K-wires. The investigators will recruit patients prospectively from the emergency room or clinic referrals. All patients who meet the inclusion and exclusion criteria will be asked to participate by the attending surgeon or resident. The patients will be assigned a number according to chronological presentation. The patients will be recruited from academic centers in Canada. Three centers, Halifax, Toronto and McMaster, do not perform CRIF with K-wires in a clinical setting and thus will represent the main operating room cohort. The clinical setting CRIF cohort will be comprised of patients from St. John, Calgary, Ottawa, Vancouver and St John's where CRIF of hand fractures are routinely performed under local anaesthetic and field sterility. The characteristics of the injury, fracture, timing of injury, patient comorbidities which predispose to infections, handedness, smoking status, sex and age will be recorded. All procedures in the operating room or the clinic area will be performed under the anaesthetic that is standard in that center. A procedure will be deemed "field sterility" if the usual surgical preparation of povidone-iodine or isopropyl alcohol-chlorohexidine gluconate and sterile drape is performed with sterile gloves and masks but without surgical gowns. In the outpatient clinic area, a basic tray will be used along with the K-wire driver and wire-cutters. A mini C-arm fluoroscopy machine is used to visualize the reduction and placement of the K-wires. The patients will then be dressed with a non-antibiotic containing dressing and splinted. The surgical information such as number and type of K-wires, OR time, type of anaesthesia, place of operation, and antibiotic use will be recorded. There will be no additional pin site care offered, as there is no standard accepted method to decrease pin-tract infection. They will be followed up as per the local protocol. The patients will be instructed that if they are concerned regarding a complication or infection that they must present to their attending surgeon or other plastic surgery colleague covering outpatient calls. They will be provided a contact number for after hours. The necessity to contact the attending team will be stressed to improve documentation of complications and ensure that the proper diagnosis of an infection will be made and appropriate antibiotic coverage started. If the patient is to present to the emergency department or family physician, improper antibiotic coverage may be started for a patient presenting with normal wound healing, which will falsely elevate the incidence of recorded hand infections. The patient will be followed until K-wire removal around 3 to 4 weeks, as per local protocol, and the duration of K-wire fixation will be recorded along with any complications.


Recruitment information / eligibility

Status Completed
Enrollment 1042
Est. completion date September 29, 2021
Est. primary completion date September 29, 2021
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: 1. Adult patients presenting with an acute metacarpal or phalangeal fracture amenable to closed reduction and percutaneous pinning. Exclusion Criteria: 1. Fractures that cannot be reduced in a closed manner necessitating open reduction internal fixation 2. Multiple fractures or significant injury requiring ORIF by other means - such as plate fixation 3. Existing infection 4. Pathologic fracture 5. CRIF performed during replantation or revascularization of digit 6. Concomitant injury (tendon injury, nerve injury, soft tissue loss requiring reconstructive procedure such as graft or flap) 7. Other disease according to investigator's judgment

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Closed Reduction Internal Fixation
K-wires placed percutaneously through the skin to achieve fixation of a hand after reduction of the fracture in a closed manner.

Locations

Country Name City State
Canada St. Martha's Regional Hospital Antigonish Nova Scotia
Canada Univeristy of Calgary Calgary Alberta
Canada Dalhousie University Halifax Nova Scotia
Canada McMaster University Hamilton Ontario
Canada McGill University Montréal Quebec
Canada University of Montreal Montréal Quebec
Canada Fraser Health New Westminster British Columbia
Canada Univeristy of Ottawa Ottawa Ontario
Canada Horizon Health Network Saint John New Brunswick
Canada Saint-Hyacinthe Saint-Hyacinthe Quebec
Canada Memorial University St. John's Newfoundland and Labrador
Canada University of Toronto Toronto Ontario
Canada Lion's Gate Hospital Vancouver British Columbia
Canada University of Manitoba Winnipeg Manitoba
Philippines Philippine Orthopedic Center, Ma. Clara Corner Banawe Street Quezon City

Sponsors (1)

Lead Sponsor Collaborator
Horizon Health Network

Countries where clinical trial is conducted

Canada,  Philippines, 

Outcome

Type Measure Description Time frame Safety issue
Primary Infection rate post closed reduction internal fixation The rate of infections after K-wire fixation of hand fractures. K-wire infection will be diagnosed if two of the three following criteria are met: i) surrounding cellulitis greater than 5mm of diameter around K wire site (more than normal inflammation) ii) purulent drainage from the pin site and iii) bacteriologic evidence of infection (ie: positive cultures). X-ray evidence of osteomyelitis will also be considered for diagnosis of late infection. 12 weeks post fixation
Secondary Complication rate post closed reduction internal fixation The rate of other complications after K-wire fixation of hand fractures. These include issues such as malunion and nonunion. 12 weeks post fixation
See also
  Status Clinical Trial Phase
Completed NCT03496337 - Is AMPS a Responsive Tool for Assessing Change in ADL-abilities After Finger or Hand Surgery
Withdrawn NCT04527588 - Italian Translation of the Michigan Hand Outcomes Questionnaire
Completed NCT03632304 - Local Anesthesia With Minimal Sedation and Brachial Plexus Block in Hand Surgery N/A
Completed NCT03555929 - Impact on Sensitivity and Motor Block Duration of an Intravenous Dexamethasone an Axillary Block With Mepivacaine. Phase 3